195 related articles for article (PubMed ID: 14696093)
1. p66Shc protein is upregulated by steroid hormones in hormone-sensitive cancer cells and in primary prostate carcinomas.
Lee MS; Igawa T; Chen SJ; Van Bemmel D; Lin JS; Lin FF; Johansson SL; Christman JK; Lin MF
Int J Cancer; 2004 Feb; 108(5):672-8. PubMed ID: 14696093
[TBL] [Abstract][Full Text] [Related]
2. Expression of p66(Shc) protein correlates with proliferation of human prostate cancer cells.
Veeramani S; Igawa T; Yuan TC; Lin FF; Lee MS; Lin JS; Johansson SL; Lin MF
Oncogene; 2005 Nov; 24(48):7203-12. PubMed ID: 16170380
[TBL] [Abstract][Full Text] [Related]
3. Tyrosine-317 of p52(Shc) mediates androgen-stimulated proliferation signals in human prostate cancer cells.
Lee MS; Igawa T; Lin MF
Oncogene; 2004 Apr; 23(17):3048-58. PubMed ID: 14990987
[TBL] [Abstract][Full Text] [Related]
4. Elevated levels of p66 Shc are found in breast cancer cell lines and primary tumors with high metastatic potential.
Jackson JG; Yoneda T; Clark GM; Yee D
Clin Cancer Res; 2000 Mar; 6(3):1135-9. PubMed ID: 10741744
[TBL] [Abstract][Full Text] [Related]
5. Mitochondrial redox signaling by p66Shc is involved in regulating androgenic growth stimulation of human prostate cancer cells.
Veeramani S; Yuan TC; Lin FF; Lin MF
Oncogene; 2008 Aug; 27(37):5057-68. PubMed ID: 18504439
[TBL] [Abstract][Full Text] [Related]
6. Constitutively tyrosine phosphorylated p52 Shc in breast cancer cells: correlation with ErbB2 and p66 Shc expression.
Stevenson LE; Frackelton AR
Breast Cancer Res Treat; 1998 May; 49(2):119-28. PubMed ID: 9696394
[TBL] [Abstract][Full Text] [Related]
7. Tamoxifen interferes with the insulin-like growth factor I receptor (IGF-IR) signaling pathway in breast cancer cells.
Guvakova MA; Surmacz E
Cancer Res; 1997 Jul; 57(13):2606-10. PubMed ID: 9205064
[TBL] [Abstract][Full Text] [Related]
8. p66Shc is indispensable for phenethyl isothiocyanate-induced apoptosis in human prostate cancer cells.
Xiao D; Singh SV
Cancer Res; 2010 Apr; 70(8):3150-8. PubMed ID: 20354186
[TBL] [Abstract][Full Text] [Related]
9. Shc proteins are strong, independent prognostic markers for both node-negative and node-positive primary breast cancer.
Davol PA; Bagdasaryan R; Elfenbein GJ; Maizel AL; Frackelton AR
Cancer Res; 2003 Oct; 63(20):6772-83. PubMed ID: 14583473
[TBL] [Abstract][Full Text] [Related]
10. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.
Unni E; Sun S; Nan B; McPhaul MJ; Cheskis B; Mancini MA; Marcelli M
Cancer Res; 2004 Oct; 64(19):7156-68. PubMed ID: 15466214
[TBL] [Abstract][Full Text] [Related]
11. Downregulated adaptor protein p66(Shc) mitigates autophagy process by low nutrient and enhances apoptotic resistance in human lung adenocarcinoma A549 cells.
Zheng Z; Yang J; Zhao D; Gao D; Yan X; Yao Z; Liu Z; Ma Z
FEBS J; 2013 Sep; 280(18):4522-30. PubMed ID: 23815759
[TBL] [Abstract][Full Text] [Related]
12. Involvement of Shc in the signaling response of human prostate tumor cell lines to epidermal growth factor.
Gresham J; Margiotta P; Palad AJ; Somers KD; Blackmore PF; Wright GL; Schellhammer PF; Wasilenko WJ
Int J Cancer; 1998 Sep; 77(6):923-7. PubMed ID: 9714065
[TBL] [Abstract][Full Text] [Related]
13. Oxidative stress stimulates apoptosis and activates NF-kappaB in osteoblastic cells via a PKCbeta/p66shc signaling cascade: counter regulation by estrogens or androgens.
Almeida M; Han L; Ambrogini E; Bartell SM; Manolagas SC
Mol Endocrinol; 2010 Oct; 24(10):2030-7. PubMed ID: 20685851
[TBL] [Abstract][Full Text] [Related]
14. The silence of p66(Shc) in HCT8 cells inhibits the viability via PI3K/AKT/Mdm-2/p53 signaling pathway.
Zhang L; Zhu S; Shi X; Sha W
Int J Clin Exp Pathol; 2015; 8(8):9097-104. PubMed ID: 26464652
[TBL] [Abstract][Full Text] [Related]
15. Endothelin-1 induces serine phosphorylation of the adaptor protein p66Shc and its association with 14-3-3 protein in glomerular mesangial cells.
Foschi M; Franchi F; Han J; La Villa G; Sorokin A
J Biol Chem; 2001 Jul; 276(28):26640-7. PubMed ID: 11342545
[TBL] [Abstract][Full Text] [Related]
16. p66 Shc and tyrosine-phosphorylated Shc in primary breast tumors identify patients likely to relapse despite tamoxifen therapy.
Frackelton AR; Lu L; Davol PA; Bagdasaryan R; Hafer LJ; Sgroi DC
Breast Cancer Res; 2006; 8(6):R73. PubMed ID: 17196107
[TBL] [Abstract][Full Text] [Related]
17. Androgen up-regulates epidermal growth factor receptor expression and binding affinity in PC3 cell lines expressing the human androgen receptor.
Brass AL; Barnard J; Patai BL; Salvi D; Rukstalis DB
Cancer Res; 1995 Jul; 55(14):3197-203. PubMed ID: 7606741
[TBL] [Abstract][Full Text] [Related]
18. Reactive oxygen species induced by p66Shc longevity protein mediate nongenomic androgen action via tyrosine phosphorylation signaling to enhance tumorigenicity of prostate cancer cells.
Veeramani S; Chou YW; Lin FC; Muniyan S; Lin FF; Kumar S; Xie Y; Lele SM; Tu Y; Lin MF
Free Radic Biol Med; 2012 Jul; 53(1):95-108. PubMed ID: 22561705
[TBL] [Abstract][Full Text] [Related]
19. A novel role of Shc adaptor proteins in steroid hormone-regulated cancers.
Alam SM; Rajendran M; Ouyang S; Veeramani S; Zhang L; Lin MF
Endocr Relat Cancer; 2009 Mar; 16(1):1-16. PubMed ID: 19001530
[TBL] [Abstract][Full Text] [Related]
20. Involvement of SHC, GRB2, SOS and RAS in prolactin signal transduction in mammary epithelial cells.
Das R; Vonderhaar BK
Oncogene; 1996 Sep; 13(6):1139-45. PubMed ID: 8808687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]